Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and long-term safety of oral TK61406 vs placebo in adults with bowel habit abnormalities
jRCT1091220210Completed
- Sponsor
- Tokai Pickling
- Start
- Mar 2015
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial in constipation, diarrhea and functional bowel disorder (FBD) comparing TK61406 with Placebo (2 arms). Primary endpoints: Safety primary evaluation items and Efficacy primary evaluation items. Started Mar 2015; status: completed.
02
Drugs
TK61406
03
Conditions
constipationdiarrheafunctional bowel disorder (FBD)
Beyond the preview
Go deeper on jRCT1091220210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220210.